2019PubMedRequires access

[Clinicopathological and molecular features of Erdheim-Chester disease accompanied with Langerhans cell histiocytosis].

Hailong Huang, Dingrong Zhong

Open publisher page 2 citations

Abstract

ECD combined LCH was a very rare histiocytosis tumor and its correct diagnosis relies on histopathologic features, immunohistochemical staining, and BRAF V600E gene detection.

About this research paper

What this paper is about

ECD combined LCH was a very rare histiocytosis tumor and its correct diagnosis relies on histopathologic features, immunohistochemical staining, and BRAF V600E gene detection.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ECD combined LCH was a very rare histiocytosis tumor and its correct diagnosis relies on histopathologic features, immunohistochemical staining, and BRAF V600E gene detection.

Key concepts: Langerin, Erdheim–Chester disease, Histiocyte, Langerhans cell histiocytosis, Pathology, CD68, Histiocytosis, Giant cell

Related papers

Back to paper searchBrowse research topicsOriginal source
[Clinicopathological and molecular features of Erdheim-Chester disease accompanied with Langerhans cell histiocytosis]. — Research Paper | ScholarLens